On Monday, Shares of Cara Therapeutics Inc (NASDAQ:CARA), subtract -1.16% and closed at 7.66 in the last trading session. The last trading range of the stock ranges between $7.53 and 7.79. Cara Therapeutics, Inc. (CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting peripheral kappa opioid receptors, recently declared its participation at two forthcoming medical meetings, both of which will be held in Chicago.
At the 10th Annual Pain & Migraine Therapeutics Summit (to be held October 19-20, 2016), Dr. Joseph Stauffer, Cara’s Chief Medical Officer, will speak on an expert panel and deliver a presentation on kappa opioid receptor agonists (KORAs) as a novel approach to acute and chronic pain administration.
At ANESTHESIOLOGY® 2016 (to be held October 22-26, 2016), Dr. Stauffer will moderate a satellite symposium discussing therapies presently used in improved recovery after surgery, and review the unique pharmacological properties of CR845, Cara’s first-in-class peripherally selective kappa opioid agonist. Clinical trial results to date support the view that CR845 is unlikely to be recreationally abused or lead to physical dependence.
FLIR Systems, Inc. (NASDAQ:FLIR), dropped -1.02% and closed at $28.98 in the last trading session. The last trading range of the stock ranges between 28.26 and 29.09. The company’s Market capitalization is $3.98 Billion with the total Outstanding Shares of 137.28 million. FLIR Systems, Inc. ( NASDAQ : FLIR ) recently declared that it plans to release financial results for the third quarter 2016, at about 7:30 a.m. ET (4:30 a.m. PT) on Wednesday, October 26, 2016.
FLIR Systems, Inc. is a world leader in the design, manufacture, and marketing of sensor systems that enhance perception and awareness. The Company’s advanced thermal imaging and threat detection systems are used for a wide variety of imaging, thermography, and security applications, counting airborne and ground-based surveillance, condition monitoring, research and development, manufacturing process control, search and rescue, drug interdiction, navigation, transportation safety, border and maritime patrol, environmental monitoring, and chemical, biological, radiological, nuclear, and explosives (CBRNE) detection.